Literature DB >> 8317548

Viral infection and dissemination through the olfactory pathway and the limbic system by Theiler's virus.

Y Wada1, R S Fujinami.   

Abstract

Theiler's murine encephalomyelitis virus (TMEV) infection of mice can produce a biphasic disease of the central nervous system (CNS). Most susceptible strains of mice survive the acute infection and develop a chronic demyelinating disease. In this report, we analyzed the routes of spread of TMEV within the CNS of nude mice and target sites eventually infected in the CNS. Compared to the immunocompetent mouse, in which an antiviral immune response is mounted but virus persists, the nude mouse develops a severe encephalomyelitis due to the lack of functional T lymphocytes and provides a useful model for the study of viral dissemination. We demonstrated, by immunohistochemistry, the presence of viral antigen in defined regions of the CNS, corresponding to various structures of the limbic system. In addition, we found a different time course for viral spread using two different sites of intracerebral inoculation, ie, via the olfactory bulb or the cortex. Limbic structures were rapidly infected following olfactory bulb infection and then showed a decrease in viral load, presumably due to loss of target neurons. Using either route of infection, the virus was able to disseminate to similar regions. These results indicate that limbic structures and their connections are very important for the spread of TMEV in the brain. In the spinal cord, not only neuronal but hematogenous pathways were suspected to be involved in the dissemination of Theiler's virus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8317548      PMCID: PMC1886942     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

2.  Neuronal and transneuronal tracing in the trigeminal system of the rat using the herpes virus suis.

Authors:  X Martin; M Dolivo
Journal:  Brain Res       Date:  1983-08-29       Impact factor: 3.252

3.  DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice.

Authors:  R P Roos; R Wollmann
Journal:  Ann Neurol       Date:  1984-05       Impact factor: 10.422

4.  Theiler's virus-induced demyelination: prevention by immunosuppression.

Authors:  H L Lipton; M C Dal Canto
Journal:  Science       Date:  1976-04-02       Impact factor: 47.728

5.  Primary demyelination in Theiler's virus infection. An ultrastructural study.

Authors:  M C Dal Canto; H L Lipton
Journal:  Lab Invest       Date:  1975-12       Impact factor: 5.662

6.  Contrasting effects of immunosuppression on Theiler's virus infection in mice.

Authors:  H L Lipton; C D Canto
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

7.  Pathogenesis of neurovirulent influenza A virus infection in mice. Route of entry of virus into brain determines infection of different populations of cells.

Authors:  M Reinacher; J Bonin; O Narayan; C Scholtissek
Journal:  Lab Invest       Date:  1983-12       Impact factor: 5.662

8.  Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis.

Authors:  M Rodriguez; J L Leibowitz; P W Lampert
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

9.  The distribution of herpes simplex type 1 antigen in mouse central nervous system after different routes of inoculation.

Authors:  J R Anderson; H J Field
Journal:  J Neurol Sci       Date:  1983-08       Impact factor: 3.181

10.  Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins.

Authors:  S D Miller; R J Clatch; D C Pevear; J L Trotter; H L Lipton
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

View more
  14 in total

1.  The GDVII strain of Theiler's virus spreads via axonal transport.

Authors:  C Martinat; N Jarousse; M C Prévost; M Brahic
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Specific infection and destruction of dopaminergic neurons in the substantia nigra by Theiler's virus.

Authors:  K R Oliver; P Brennan; J K Fazakerley
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.

Authors:  I Tsunoda; Y Wada; J E Libbey; T S Cannon; F G Whitby; R S Fujinami
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system.

Authors:  N Jarousse; C Martinat; S Syan; M Brahic; A McAllister
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease.

Authors:  Y Wada; M L Pierce; R S Fujinami
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

6.  Human herpesvirus-6 entry into the central nervous system through the olfactory pathway.

Authors:  Erin Harberts; Karen Yao; Jillian E Wohler; Dragan Maric; Joan Ohayon; Robert Henkin; Steven Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

7.  Peripheral nerve protein, P0, as a potential receptor for Theiler's murine encephalomyelitis virus.

Authors:  J E Libbey; I J McCright; I Tsunoda; Y Wada; R S Fujinami
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

Review 8.  Review part 2: Human herpesvirus-6 in central nervous system diseases.

Authors:  Karen Yao; John R Crawford; Anthony L Komaroff; Dharam V Ablashi; Steven Jacobson
Journal:  J Med Virol       Date:  2010-10       Impact factor: 2.327

9.  Mode of spread to and within the central nervous system after oral infection of neonatal mice with the DA strain of Theiler's murine encephalomyelitis virus.

Authors:  Y M Ha-Lee; K Dillon; B Kosaras; R Sidman; P Revell; R Fujinami; M Chow
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  B-lymphocyte requirement for vaccine-mediated protection from Theiler's murine encephalomyelitis virus-induced central nervous system disease.

Authors:  C I Kurtz; X M Sun; R S Fujinami
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.